patient_id	feature_display	tested_subfeature	therapy_name	n_mut	n_wt	n_mut_tested	n_wt_tested	mut_ic50_median	mut_ic50_mean	mut_ic50_std	wt_ic50_median	wt_ic50_mean	wt_ic50_std	pvalue_mww	statistic
MEL-IPI_Pat88	KIT p.V559G (Missense)	KIT	Imatinib	131	1692	35	372	18.167	20.991	14.549	18.314	21.315	16.18	0.905	6589.5
MEL-IPI_Pat88	KIT p.V559G (Missense)	KIT Somatic Variant	Imatinib	77	1746	24	383	17.788	19.919	13.952	18.401	21.373	16.163	0.59	4898.0
MEL-IPI_Pat88	KIT p.V559G (Missense)	KIT Somatic Variant Missense	Imatinib	71	1752	23	384	18.113	20.026	14.256	18.358	21.363	16.143	0.605	4700.0
MEL-IPI_Pat88	KIT p.V559G (Missense)	KIT Somatic Variant Missense p.V559G	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF	Dabrafenib	264	1559	136	621	34.824	120.732	228.705	121.915	244.298	422.653	2.322e-12	58428.0
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF Somatic Variant	Dabrafenib	184	1639	98	659	19.092	80.76	176.13	120.697	243.118	416.712	7.627e-17	49130.0
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF Somatic Variant Missense	Dabrafenib	170	1653	89	668	19.04	82.289	184.013	119.74	240.726	414.446	6.330e-16	45390.0
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF Somatic Variant Missense p.P632S	Dabrafenib	0	1823	0	757				106.703	222.099	397.61	nan	
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF	Trametinib	264	1559	137	634	0.516	5.862	27.545	2.112	7.605	32.168	2.344e-09	57546.5
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF Somatic Variant	Trametinib	184	1639	99	672	0.364	4.887	30.17	2.152	7.65	31.568	9.083e-13	48043.5
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF Somatic Variant Missense	Trametinib	170	1653	90	681	0.271	5.095	31.639	2.147	7.586	31.365	2.900e-13	45139.0
MEL-IPI_Pat88	BRAF p.P632S (Missense)	BRAF Somatic Variant Missense p.P632S	Trametinib	0	1823	0	771				1.844	7.295	31.386	nan	
MEL-IPI_Pat88	EGFR p.R932P (Missense)	EGFR	Osimertinib	242	1581	138	614	4.126	9.455	14.253	5.746	11.61	24.66	0.006	48749.0
MEL-IPI_Pat88	EGFR p.R932P (Missense)	EGFR Somatic Variant	Osimertinib	120	1703	67	685	4.392	9.78	15.814	5.593	11.355	23.708	0.1	25741.0
MEL-IPI_Pat88	EGFR p.R932P (Missense)	EGFR Somatic Variant Missense	Osimertinib	103	1720	59	693	4.095	10.132	16.631	5.593	11.306	23.587	0.128	22883.0
MEL-IPI_Pat88	EGFR p.R932P (Missense)	EGFR Somatic Variant Missense p.R932P	Osimertinib	0	1823	0	752				5.522	11.214	23.111	nan	
MEL-IPI_Pat88	KIT p.P573S (Missense)	KIT	Imatinib	131	1692	35	372	18.167	20.991	14.549	18.314	21.315	16.18	0.905	6589.5
MEL-IPI_Pat88	KIT p.P573S (Missense)	KIT Somatic Variant	Imatinib	77	1746	24	383	17.788	19.919	13.952	18.401	21.373	16.163	0.59	4898.0
MEL-IPI_Pat88	KIT p.P573S (Missense)	KIT Somatic Variant Missense	Imatinib	71	1752	23	384	18.113	20.026	14.256	18.358	21.363	16.143	0.605	4700.0
MEL-IPI_Pat88	KIT p.P573S (Missense)	KIT Somatic Variant Missense p.P573S	Imatinib	0	1823	0	407				18.312	21.287	16.03	nan	
MEL-IPI_Pat88	FLT3 p.G636E (Missense)	FLT3	Sunitinib	190	1633	52	346	15.1	46.352	71.421	10.402	33.152	60.495	0.319	8225.0
MEL-IPI_Pat88	FLT3 p.G636E (Missense)	FLT3 Somatic Variant	Sunitinib	78	1745	25	373	6.801	41.337	83.169	10.855	34.444	60.541	0.187	5398.0
MEL-IPI_Pat88	FLT3 p.G636E (Missense)	FLT3 Somatic Variant Missense	Sunitinib	68	1755	20	378	4.73	33.386	83.789	11.104	34.956	60.877	0.031	4864.0
MEL-IPI_Pat88	FLT3 p.G636E (Missense)	FLT3 Somatic Variant Missense p.G636E	Sunitinib	0	1823	0	398				10.692	34.877	62.092	nan	
MEL-IPI_Pat88	MET p.E221K (Missense)	MET	SU11274	199	1624	123	801	58.163	79.735	81.446	42.785	68.665	76.237	0.129	45080.0
MEL-IPI_Pat88	MET p.E221K (Missense)	MET Somatic Variant	SU11274	88	1735	57	867	50.407	79.148	84.131	43.459	69.547	76.52	0.485	23347.0
MEL-IPI_Pat88	MET p.E221K (Missense)	MET Somatic Variant Missense	SU11274	74	1749	46	878	52.016	72.185	69.765	43.659	70.032	77.392	0.663	19425.0
MEL-IPI_Pat88	MET p.E221K (Missense)	MET Somatic Variant Missense p.E221K	SU11274	0	1823	0	924				44.064	70.139	76.997	nan	
